This Article Full Text Full Text (PDF) Supplemental material Other Versions of this Article: MCB.00940-06v1 26/23/8683    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, Y. Articles by Jones, D. R. Search for Related Content PubMed PubMed Citation Articles by Liu, Y. Articles by Jones, D. R.

Breast Cancer Metastasis Suppressor 1 Functions as a Corepressor by Enhancing Histone Deacetylase 1-Mediated Deacetylation of RelA/p65 and Promoting Apoptosis ^,

Department of Surgery, University of Virginia School of Medicine, Charlottesville, Virginia

Received 26 May 2006/ Returned for modification 1 August 2006/ Accepted 11 September 2006

The antiapoptotic transcription factor NF-B is constitutively activated in many cancers and is important for cytokine-mediated progression and metastatic movement of tumors. Breast cancer metastasis suppressor 1 (BRMS1) is a metastasis suppressor gene whose mechanisms of action are poorly understood. In this report, we demonstrate that BRMS1 decreases the transactivation potential of RelA/p65 and ameliorates the expression of NF-B-regulated antiapoptotic gene products. BRMS1 immunoprecipitates with the RelA/p65 subunit of NF-B with protein-protein interactions occurring at the C terminus region of the rel homology domain but not at its known transactivation domains. Moreover, BRMS1 functions as a corepressor by promoting binding of HDAC1 to RelA/p65, where it deacetylates lysine K310 on RelA/p65, which suppresses RelA/p65 transcriptional activity. Selective small interfering RNA knockdown of BRMS1 confirms that chromatin-bound BRMS1 is required for deacetylation of RelA/p65, while enhancing chromatin occupancy of HDAC1 onto the NF-B-regulated promoters cIAP2 and Bfl-1/A1. We observed in cells lacking BRMS1 a dramatic increase in cell viability after the loss of attachment from the extracellular matrix. Collectively, these results suggest that BRMS1 suppresses metastasis through its ability to function as a transcriptional corepressor of antiapoptotic genes regulated by NF-B.

Published ahead of print on 25 September 2006.

Supplemental material for this article may be found at http://mcb.asm.org/.

This article has been cited by other articles:

• Hurst, D. R., Xie, Y., Vaidya, K. S., Mehta, A., Moore, B. P., Accavitti-Loper, M. A., Samant, R. S., Saxena, R., Silveira, A. C., Welch, D. R. (2008). Alterations of BRMS1-ARID4A Interaction Modify Gene Expression but Still Suppress Metastasis in Human Breast Cancer Cells. J. Biol. Chem. 283: 7438-7444 [Abstract] [Full Text]  
• Phadke, P. A., Vaidya, K. S., Nash, K. T., Hurst, D. R., Welch, D. R. (2008). BRMS1 Suppresses Breast Cancer Experimental Metastasis to Multiple Organs by Inhibiting Several Steps of the Metastatic Process. Am. J. Pathol. 172: 809-817 [Abstract] [Full Text]  
• Milstein, M., Mooser, C. K., Hu, H., Fejzo, M., Slamon, D., Goodglick, L., Dry, S., Colicelli, J. (2007). RIN1 Is a Breast Tumor Suppressor Gene. Cancer Res. 67: 11510-11516 [Abstract] [Full Text]